Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66,413,214
-
Total 13F shares
-
21,585,028
-
Share change
-
-72,427
-
Total reported value
-
$78,141,598
-
Price per share
-
$3.62
-
Number of holders
-
33
-
Value change
-
-$4,791,434
-
Number of buys
-
16
-
Number of sells
-
12
Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q2 2022
As of 30 Jun 2022,
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,585,028 shares.
The largest 10 holders included
GENERATION INVESTMENT MANAGEMENT LLP, BANQUE PICTET & CIE SA, PRICE T ROWE ASSOCIATES INC /MD/, CREDIT SUISSE AG/, PFM Health Sciences, LP, Alta Wealth Advisors LLC, JENNISON ASSOCIATES LLC, GENERAL ELECTRIC CO, PRINCIPAL FINANCIAL GROUP INC, and PURA VIDA INVESTMENTS, LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.